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 Introduction 
 Cutaneous collagenous vasculopathy 
(CCV) is a rare microangiopathy of un-
known origin, which involves the superficial 
cutaneous vasculature  [1] . CCV typically 
develops in middle-aged patients with cuta-
neous telangiectasia on the trunk, lower and 
upper limbs. Cutaneous lesions are usually 
asymptomatic but sometimes disfiguring. 
The perivascular fibrosis is thought to be 
due to the production of abnormal collagen 
by veil cells in the outer vessel walls as a re-
sult of unknown factors  [1] . Although there 
is no cure for this usually chronic and pro-
gressive condition, vascular laser should be 
considered to significantly improve both 
skin lesions and the quality of life of affected 
patients. These were successfully treated for 
the first time with an optimized pulsed light 
(OPL) combined with a multiplex sequen-
tial PDL 595-nm/Nd:YAG 1,064-nm laser, 
and we review previous cases of CCV and 
available therapeutic options.
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 Abstract 
 Cutaneous collagenous vasculopathy (CCV) 
is a rare idiopathic microangiopathy of the 
cutaneous vasculature characterized histo-
logically by the presence of dilated small 
blood vessels with flat endothelial cells and 
thickened walls containing hyaline material 
in the upper dermis. We report an elderly pa-
tient presenting with an extensive form of 
CCV involving the trunk, upper and lower 
limbs. She was treated with Multiplex PDL 
595-nm/Nd:YAG 1,064-nm laser and opti-
mized pulsed light. This approach, which has 
never been reported for CCV so far, resulted 
in a striking and almost complete clearance 
of the widespread lesions. We here review 
our knowledge about CCV and therapeutic 
options available with a survey of the litera-
ture.  © 2015 S. Karger AG, Basel 
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 Case Report 
 A 77-year-old woman was evaluated for 
generalized asymptomatic telangiectasias 
( fig. 1 a). The lesions had first developed by 
the age of 20 years on the lower legs and 
subsequently spread onto the thighs, arms 
and chest. The family history was unre-
markable. The medical history revealed 
surgery for ovarian cystic adenocarcinoma, 
ischemic heart disease with arrhythmias 
and chronic renal insufficiency with gen-
eralized itch. The patient was on phen-
procoumon, acetylsalicylic acid, oxazepam 
and levocetirizine.
 Physical examination showed wide-
spread telangiectasias distributed symmet-
rically on the legs, arms and chest. Some 
lesions were raised, slightly hypertrophic 
 D.B., S.R., L.B. and M.A. contributed equally. 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
 B
er
n 
   
   
   
   
   
   
   
   
   
   
   
   
  
19
8.
14
3.
58
.1
 - 
3/
9/
20
16
 1
:5
4:
59
 P
M
s
o
u
r
c
e
:
 
ht
tp
:/
/b
or
is
.u
ni
be
.c
h/
76
59
2/
 
| 
do
wn
lo
ad
ed
: 
13
.3
.2
01
7
 Basso/Ribero/Blazek/Dietrich/
Beltraminelli/Ramelet/Borradori/Adatto
 
Dermatology 2016;232:107–111
DOI: 10.1159/000439126
108
and more of a purple color, while some oth-
ers were completely flat and bright red. 
There was no mucosal or nail involvement.
 Light microscopy studies of a biopsy 
specimen obtained from the leg revealed 
dilated superficial cutaneous vessels with 
perivascular deposits of hyaline materi-
al ( fig.  2 a). A staining with collagen type
IV was visible at immunohistochemistry 
( fig. 2 b).
 The patient desired to improve the dis-
turbing cosmetic appearance of these ex-
tensive red-blue lesions, especially on the 
arms and forearms. We proposed laser 
treatment using a combination of a Multi-
plex PDL 595-nm/Nd:YAG 1,064-nm laser 
as well as an OPL. The following parame-
ters were used, as spot tests first, with the 
laser, on the hypertrophic lesions: 595-nm 
pulsed dye laser, a 7-mm spot at 8.5 J/cm 2 
and a 10-ms pulse duration followed se-
quentially by a 500-ms interval, then a 
pulse of 1,064-nm Nd:YAG laser at 55 J/
cm 2 and a 15-ms pulse duration (Cynergy 
Multiplex, Cynosure, Westford, Mass., 
USA). This was delivered in a single pass 
with no overlap. Forced chilled air was
used for parallel cooling. For flat lesions, 
we used an OPL (Limelight Cutera, Bris-
bane, Calif., USA) with a 520-nm filter, a
10 × 30 mm spot, fluence range of 16–18
J/cm 2 , 8–9 ms of pulse width, with contact 
cooling and 2 perpendicular passes. The re-
sponse of these tests gave a remarkable im-
provement. Therefore all lesions of the up-
per limbs and trunk were subsequently 
treated using the same parameters. Almost 
complete clearance of the telangiectasia on 
both arms and the chest was obtained after 
a total of 7 combined laser/intense pulsed 
light treatment sessions, performed every 
4–8 weeks ( fig. 1 b).
 Discussion 
 Our patient had clinical and histopath-
ological features typically described as 
CCV, a distinctive primary cutaneous mi-
croangiopathy first described in 2000  [1, 2] . 
This entity is rare since only 25 cases have 
been described so far in the English litera-
ture ( table 1 ).
 CCV has almost exclusively been re-
ported in middle-aged subjects  [3] , even 
though 1 pediatric case has been reported 
 [4] . In our patient, cutaneous telangiectasia 
originally developed on the lower legs and 
progressed subsequently to the thighs, 
trunk and the upper extremities in accor-
dance with data reported in the literature 
 [5] . Usually lesions are almost invariably 
asymptomatic although some itching may 
occur  [5] . Lesions remain then relatively 
stable or may occasionally worsen during 
the summer months  [2] . No mucosal in-
volvement has been reported so far.
 Light microscopy studies are essential 
for the diagnosis of CCV. This typically 
shows dilated small blood vessels in the su-
perficial dermis and, more rarely, in the 
midreticular dermis. Sparse lymphocytes 
scattered around the vessel walls may be 
found. Electron microscopy studies dis-
close dilated postcapillary venules with flat 
endothelial cells and a thickened laminat-
a b
c d
a b
 Fig. 1.  a Diffuse acquired telangiectasias over the arms and chest.  b Close-up view of the 
right arm.  c Postintervention resolution of the telangiectasias over the arms and the chest. 
 d Postintervention close-up view of the right arm. 
 Fig. 2.  a Telangiectasia of dermal capillaries with hyalinized thickening of the vessel wall. 
 b The hyaline material within the thick vessel wall is positive for collagen type IV. 
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 Table 1.  Survey of the literature: cases of CCV and their management
No. Authors Age, 
years
Sex Race Medical history Distribution Evolution Treatment
1 Salama and 
Rosenthal [1], 
2000
54 M Caucasian Depression Trunk, upper and lower 
limbs
5 years No
2 Davis et al. [6], 
2008
59 M Caucasian Diabetes mellitus, hypercholesterolemia, 
hypertension
Forearm, chest, abdomen 7 months No
6 M Caucasian Diabetes mellitus, hypertension, psoriasis Thigh Unclear No
80 M Caucasian Atrial fibrillation, gastroesophageal reflux, venous 
insufficiency
Abdomen, thigh, back, 
hands
Unclear No
3 Kanitakis et al. 
[8], 2010
65 M Caucasian Hypertension, coronary infarction, prostatic 
adenoma
Lower extremities, 
abdomen, buttocks, back
5–6 years No
4 Monteagudo
et al. [11], 2010
68 M Caucasian Hypertension, hypercholesterolemia, prostatic 
adenoma, hyperuricemia
Forearm, abdomen, 
lower limbs
15 years No
5 Perez et al. [7], 
2010
51 F Caucasian Hypothyroidism, psoriasis Trunk, neck, upper 
and lower limbs, 
retroauricular area
16 years No
71 F Caucasian Pituitary tumor, osteoporosis Feet, knees, upper limbs, 
chest, cheeks
7 years No
6 Lloyd et al. [4], 
2011
16 F Caucasian Mood disorders Trunk, legs 3 years No
7 González
Fernández
et al. [3], 2012
83 F Caucasian Atrial fibrillation, mitral valve disease, hepatitis C, 
hypertension
Upper and lower limbs, 
abdomen
>20 years No
74 F Caucasian Discoid lupus, venous insufficiency Lower limbs No
8 Echeverría
et al. [14], 2012
42 F Caucasian – Upper and lower limbs, 
abdomen
7 years PDL, 
successful
9 Burdick et al. 
[2], 2012
68 M Unknown Macular degeneration since childhood, 
hypertension, hyperlipidemia, gastroesophageal 
reflux disease
Legs, abdomen Several weeks No
59 M Unknown Diabetes mellitus, hypertension, hyperlipidemia, 
osteoarthritis, depression
Arms, legs Several 
months
No
70 M Unknown Hypertension, diabetes mellitus, 
hypercholesterolemia
Right leg 10 years No
41 F Unknown Basal cell carcinoma, inactive hepatitis Arms Several years No
10 Bernard et al.
[21], 2012
47 F Unknown Diabetes mellitus type 1, psoriasis, hypertension, 
hypothyroidism
Lower limbs, abdomen 1–2 years No
11 Salama et al. [5], 
2014
84 M Caucasian Myelodysplastic syndrome, diabetes mellitus, celiac 
disease, tuberculosis, tachycardia
Lower limbs and trunk 3 years No
12 Salama [22], 
2015
68 F Unknown Mild chronic renal failure,
cryofibrinogenemia
Lower limbs Unknown –
85 F Unknown Diabetes mellitus Lower limbs 10 years No
50 F Unknown – Lower limbs and upper 
limbs
2 years No
69 F Unknown Diabetes mellitus Lower limbs and upper 
limbs, abdomen
Unknown No
56 F Unknown – Lower limbs and upper 
limbs, trunk
25 years No
42 F Unknown Raynaud phenomenon Lower limbs >20 years No
73 M Unknown – Lower limbs and upper 
limbs
2.5 years No
13 Bardazzi et al. 
[23], 2014
57 F Caucasian Uveitis, hypertension Legs, abdomen, buttocks, 
hips, trunk, arms, malar 
region, fingers
9 years No
14 This study,
2015
77 F Caucasian Renal insufficiency, venous insufficiency, ovarian 
adenocarcinoma, ischemic heart disease
Upper and lower limbs, 
chest
>20 years PDL/
Nd:YAG
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ed basement membrane consisting of an 
amorphous eosinophilic hyaline material 
 [2, 3] . By immunohistochemistry, vascular 
cells of endothelial origin are CD31 and 
CD34 positive. The amorphous eosino-
philic hyaline material is stained using an-
tibodies directed against laminins, fibro-
nectin and, characteristically, type IV col-
lagen  [5–7] . No amyloid deposits by Congo 
red staining are found.
 CCV has to be differentiated from a 
number of other vascular disorders pre-
senting with cutaneous telangiectasias, in-
cluding benign hereditary telangiectasia, 
angioma serpiginosum and telangiectasia 
macularis eruptiva perstans  [3] . General-
ized essential telangiectasia (GET)  [8] is 
another benign condition that should be 
differentiated from CCV. At variance with 
CCV, GET is more common in women and 
can rarely also involve the oral mucosa and 
conjunctiva. In contrast to CCV, in GET 
there are dilated vessel walls, which consist 
of thickened endothelial cells, but without 
any deposition of amorphous hyaline ma-
terial  [2, 9] .
 The question remains whether the pe-
culiar histopathological findings of CCV 
are sufficient to distinguish CCV from 
GET as a distinct disease or whether both 
conditions represent different faces of a 
single disease. We included in the study 
only the certified CCV.
 The mechanisms leading to the devel-
opment of CCV remain unknown. Some 
authors have discussed a nonimmunologi-
cally related injury of the endothelial cells 
by unknown factors, which ultimately lead 
to the production of abnormal collagen 
and reparative fibrosis  [4] . The intake of 
drugs, encompassing corticosteroids, lithi-
um, tiotixene, interferon, isotretinoin, cal-
cium channel blockers, antibiotics or anti-
depressants, has been thought to act as trig-
ger  [7, 10] .
 Conditions such as diabetes mellitus or 
hypertension may further contribute. Most 
likely CCV represents a response pattern 
triggered by multiple factors  [2, 3, 11] .
 The therapy of CCV is challenging. If 
the patient wants a cosmetic improvement, 
lasers and other light sources represent the 
first therapeutic option. The latter are 
working according to the principle of selec-
tive photothermolysis  [12] . When treating 
vascular lesions, the primary target is oxy-
hemoglobin  [13] . Two cases of CCV have 
been treated by a pulsed dye laser  [14] . We 
opted for a combination of Multiplex PDL/
YAG laser on thicker, purple lesions, to-
gether with an OPL on the flatter, redder 
ones. The advantages of this combination 
of energy-based devices during the same 
session are: (a) the Multiplex laser, which 
combines PDL at 595 nm followed by YAG 
at 1,064 nm, is ideal for treating hypertro-
phic vascular lesions; this specific device 
has already been used successfully in treat-
ing various vascular conditions, with better 
vessel clearance than with a single pulsed 
laser  [15] ; (b) the OPL is an evolution of
the intense pulsed light, developed in 1992 
 [16] , as it brings true square pulse emis-
sion. This peculiarity gives a very precise 
control of delivered fluencies, similar to
a laser, even being a noncoherent light 
source. Our OPL, due to its large spot size 
(10 × 30 mm) allowed speed, comfort and 
also very good cosmetic results in treating 
large areas when compared with a laser 
with a small spot size (7–10 mm). A few 
cases of essential telangiectasias have been 
published using an intense pulsed light 
 [17–20] . To our knowledge, our case is the 
first describing a case of CCV successfully 
treated with an OPL combined with a Mul-
tiplex laser within the same session.
 In conclusion, we here describe the first 
successful case of CCV treated with an OPL 
combined with a multiplex sequential PDL 
595-nm/Nd:YAG 1,064-nm laser within 
the same session. This approach led to an 
impressive aesthetical improvement de-
spite the very large affected surface. Even if 
a causal treatment of this difficult skin dis-
ease has not already been discovered, the 
combination approach used here seems 
very effective.
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